Growthcurve Capital
Growthcurve Capital describes a control-oriented investment model for middle-market companies, with an AI-focused value-creation approach and stated equity investments of approximately $100m-$300m+ in businesses with approximately $25m-$100m of revenue.
What stands out about Growthcurve Capital
Growthcurve Capital publicly describes itself as a control equity investor focused on middle-market businesses with proprietary data, network effects, or competitive moats. It identifies Financial Services, Technology & Information Services, and Healthcare as sectors of focus and works with management on AI, product, engineering, human capital, and acquisition initiatives.[1][2][3][5]
What does Growthcurve Capital invest in?
Growthcurve Capital is a private equity firm that describes its mission as accelerating the growth of middle-market companies by operationalizing AI. The firm was founded in 2021. Its website reports $3B+ in assets under management, 37 team members, and 7 platform investments.
GrowthCurve Capital LP is identified in Form ADV as an SEC-registered investment adviser. The filing identifies the firm’s principal office at 250 West 55th Street, Suite 3301, New York, NY 10019.[1][2][6]
Growthcurve states that it makes approximately $100m-$300m+ control equity investments in businesses with approximately $25m-$100m of revenue. Its stated thesis emphasizes companies with proprietary data that can power customer decisions, multi-sided network effects, or competitive moats such as regulatory requirements, mission-criticality, or customer trust.
The firm describes partnering with management on value-creation programs using AI, Product & Engineering, and Human Capital capabilities. Its stated value-creation goals include accelerating revenue growth, building decisioning surfaces inside products, expanding addressable markets, and executing accretive acquisitions.[3]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Growthcurve Capital?
Owners evaluating a sale or control investment should clarify the governance rights Growthcurve typically seeks, the expected level of management reinvestment, financing parameters, and the scope of the firm’s management-partnership model. The firm’s stated approach includes management partnership, AI, product and engineering, human capital, and accretive acquisition capabilities, so owners may also wish to understand which capabilities would be relevant to a particular company and how add-on opportunities would be evaluated.
The official Approach page does not state an expected holding period, ownership duration, or exit timetable. Owners should therefore seek specific information about ownership duration, exit planning, management incentive arrangements, and transaction terms for any proposed deal.[3][5]
What percentage of equity and board control does Growthcurve typically seek
How much seller rollover or management reinvestment is expected
What are the preferred leverage and financing parameters
What companies does Growthcurve Capital target?
The firm states that it targets businesses with approximately $25m-$100m of revenue and makes approximately $100m-$300m+ control equity investments. It also identifies proprietary data, multi-sided network effects, and competitive moats—including regulatory requirements, mission-criticality, or customer trust—as characteristics of focus.
The official Approach page does not publish a universal minimum EBITDA threshold or enterprise-value range.[3]
Growthcurve identifies Financial Services, Technology & Information Services, and Healthcare as its sectors of focus.[2]
Growthcurve Capital lists its principal office in New York, New York. Its public portfolio includes companies headquartered in the United States and Canada, including PlanHub, PureFacts, Duetto, Netchex, Revecore, Brightway Insurance, and Mistplay.
The official Approach page does not publish a broader geographic mandate.[1][3][4]
Growthcurve’s public portfolio and News page identify platform investments and add-on transactions across software, data, healthcare, and financial-services businesses. Listed add-on activity includes Duetto’s acquisition of Hotstats; Brightway Insurance’s acquisition of GlobalGreen Insurance; Revecore’s acquisitions of Kemberton and Cura; and Mistplay’s acquisitions involving Mobivity’s Connected Rewards platform and MAF’s MyChips.[4][5]
Growthcurve’s official portfolio page identifies PlanHub, PureFacts, Duetto, Netchex, Revecore, Brightway Insurance, and Mistplay as portfolio companies.[4]
The official News page identifies Growthcurve’s announced acquisition of PlanHub on September 2, 2025; its announced majority investment in PureFacts on June 26, 2024; its announced acquisition of Duetto on April 10, 2024; and its announced acquisition of Netchex on April 23, 2023.
The page also identifies the completed acquisition of Revecore on January 14, 2022. Additional listed platform transactions include Brightway Insurance and Mistplay.
The official News page identifies platform transactions and announcement dates but does not publish transaction values or consideration terms for those listed platform transactions.[5]
What is not clear from Growthcurve Capital's public investment criteria?
The official Approach page does not state an expected investment holding period, ownership duration, or exit timetable. That page also does not publish a universal minimum EBITDA threshold, enterprise-value range, or broader geographic mandate.
The official News page identifies platform transactions and announcement dates but does not publish transaction values or consideration terms for those listed platform transactions.[3][5]
Questions to ask when evaluating Growthcurve Capital as a buyer or investment partner
What percentage of equity and board control does Growthcurve typically seek?
How much seller rollover or management reinvestment is expected?
What are the preferred leverage and financing parameters?
How does Growthcurve define its target revenue range for companies with recurring versus non-recurring revenue?
What is the expected ownership duration and exit-planning process?
How are management incentive pools structured?
What post-investment operating resources are committed, and which services carry incremental cost?
Sources & research notes
- Official website / firm overview
- Official website / firm overview
- Investment strategy
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- SEC filing / regulatory record
- SEC filing / regulatory record
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.